Podcast: Solving Major Bottlenecks in Genetic Medicine and SynBio With DNA Synthesis Innovation

Company to Watch – Elegen

As part of April 2024’s Company to Watch program, we speak to Matt Hill, founder and CEO of Elegen, about Elegen’s ENFINIA DNA technology, the need it addresses, and how it has disrupted the status quo for DNA synthesis.


This is part 2 of the Big4Bio Company to Watch program for April 2024: Elegen
For more information on the series, click here.